The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Overy, Michael John
    Director born in August 1946
    Individual (6 offsprings)
    Officer
    2013-04-22 ~ now
    OF - Director → CIF 0
    Mr Michael John Overy
    Born in August 1946
    Individual (6 offsprings)
    Person with significant control
    2017-04-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 2
    Colebrook, Christopher John
    Operations Manager born in August 1967
    Individual (6 offsprings)
    Officer
    2015-08-01 ~ now
    OF - Director → CIF 0
    Colebrook, Christopher John
    Individual (6 offsprings)
    Officer
    2015-08-01 ~ now
    OF - Secretary → CIF 0
    Mr Christopher John Colebrook
    Born in August 1967
    Individual (6 offsprings)
    Person with significant control
    2017-04-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 3
    Webb, Jason
    Head Of Hospitals born in May 1969
    Individual (2 offsprings)
    Officer
    2018-05-15 ~ now
    OF - Director → CIF 0
  • 4
    Everett, Jeffrey Raymond Albert
    Commercial Manager born in October 1966
    Individual (1 offspring)
    Officer
    2015-08-01 ~ now
    OF - Director → CIF 0
    Mr Jeffrey Raymond Albert Everett
    Born in October 1966
    Individual (1 offspring)
    Person with significant control
    2017-04-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
Ceased 1
  • Overy, Carol Ann
    Individual (1 offspring)
    Officer
    2013-04-22 ~ 2014-11-30
    OF - Secretary → CIF 0
parent relation
Company in focus

ARCADIA PHARMA LIMITED

Previous name
VERADIS PHARMA LIMITED - 2013-09-26
Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Average Number of Employees
302023-01-01 ~ 2023-12-31
292022-01-01 ~ 2022-12-31
Intangible Assets
4,809 GBP2023-12-31
7,212 GBP2022-12-31
Property, Plant & Equipment
95,770 GBP2023-12-31
64,749 GBP2022-12-31
Fixed Assets
100,579 GBP2023-12-31
71,961 GBP2022-12-31
Total Inventories
819,958 GBP2023-12-31
813,006 GBP2022-12-31
Debtors
Current
1,010,346 GBP2023-12-31
982,735 GBP2022-12-31
Cash at bank and in hand
505,124 GBP2023-12-31
32,561 GBP2022-12-31
Current Assets
2,335,428 GBP2023-12-31
1,828,302 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-1,345,356 GBP2023-12-31
-1,123,792 GBP2022-12-31
Net Current Assets/Liabilities
990,072 GBP2023-12-31
704,510 GBP2022-12-31
Total Assets Less Current Liabilities
1,090,651 GBP2023-12-31
776,471 GBP2022-12-31
Creditors
Non-current, Amounts falling due after one year
-51,019 GBP2023-12-31
-18,290 GBP2022-12-31
Net Assets/Liabilities
891,853 GBP2023-12-31
480,596 GBP2022-12-31
Equity
Called up share capital
99 GBP2023-12-31
99 GBP2022-12-31
Retained earnings (accumulated losses)
891,754 GBP2023-12-31
480,497 GBP2022-12-31
Equity
891,853 GBP2023-12-31
480,596 GBP2022-12-31
Intangible Assets - Gross Cost
Development expenditure
24,033 GBP2023-12-31
24,033 GBP2022-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Development expenditure
19,224 GBP2023-12-31
16,821 GBP2022-12-31
Intangible Assets
Development expenditure
4,809 GBP2023-12-31
7,212 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
149,096 GBP2023-12-31
143,215 GBP2022-12-31
Furniture and fittings
110,940 GBP2023-12-31
110,940 GBP2022-12-31
Computers
71,176 GBP2023-12-31
68,465 GBP2022-12-31
Property, Plant & Equipment - Gross Cost
373,702 GBP2023-12-31
322,620 GBP2022-12-31
Motor vehicles
42,490 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
143,024 GBP2022-12-31
Furniture and fittings
72,591 GBP2022-12-31
Computers
42,255 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
257,870 GBP2022-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
3,000 GBP2023-01-01 ~ 2023-12-31
Motor vehicles, Owned/Freehold
1,562 GBP2023-01-01 ~ 2023-12-31
Furniture and fittings, Owned/Freehold
8,000 GBP2023-01-01 ~ 2023-12-31
Computers, Owned/Freehold
7,500 GBP2023-01-01 ~ 2023-12-31
Owned/Freehold
20,062 GBP2023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
146,024 GBP2023-12-31
Motor vehicles
1,562 GBP2023-12-31
Furniture and fittings
80,591 GBP2023-12-31
Computers
49,755 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
277,932 GBP2023-12-31
Property, Plant & Equipment
Plant and equipment
3,072 GBP2023-12-31
191 GBP2022-12-31
Motor vehicles
40,928 GBP2023-12-31
Furniture and fittings
30,349 GBP2023-12-31
38,349 GBP2022-12-31
Computers
21,421 GBP2023-12-31
26,209 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
988,231 GBP2023-12-31
929,032 GBP2022-12-31
Called-up share capital (not paid)
Current
99 GBP2023-12-31
99 GBP2022-12-31
Prepayments/Accrued Income
Current
22,016 GBP2023-12-31
53,604 GBP2022-12-31
Bank Overdrafts
Current
41 GBP2022-12-31
Bank Borrowings
Current
10,000 GBP2023-12-31
35,833 GBP2022-12-31
Trade Creditors/Trade Payables
Current
1,058,500 GBP2023-12-31
974,205 GBP2022-12-31
Corporation Tax Payable
Current
191,744 GBP2023-12-31
57,001 GBP2022-12-31
Taxation/Social Security Payable
Current
72,785 GBP2023-12-31
42,451 GBP2022-12-31
Finance Lease Liabilities - Total Present Value
Current
6,089 GBP2023-12-31
Other Creditors
Current
6,238 GBP2023-12-31
14,261 GBP2022-12-31
Creditors
Current
1,345,356 GBP2023-12-31
1,123,792 GBP2022-12-31
Bank Borrowings
Non-current
15,833 GBP2023-12-31
Finance Lease Liabilities - Total Present Value
Non-current
35,186 GBP2023-12-31
Other Creditors
Non-current
18,290 GBP2022-12-31
Creditors
Non-current
51,019 GBP2023-12-31
18,290 GBP2022-12-31
Minimum gross finance lease payments owing
41,275 GBP2023-12-31
Related profiles found in government register
  • ARCADIA PHARMA LIMITED
    Info
    VERADIS PHARMA LIMITED - 2013-09-26
    Registered number 08497840
    Unit 3 Felinfach, Fforestfach, Swansea SA5 4HP
    Private Limited Company incorporated on 2013-04-22 (12 years 2 months). The company status is Active.
    The last date of confirmation statement was made at 2024-04-22
    CIF 0
  • ARCADIA PHARMA LIMITED
    S
    Registered number missing
    Unit 3 Bell Court, Felinfach, Fforestfach, Swansea, Wales, SA5 4HP
    Limited
    CIF 1 CIF 2 CIF 3
(more)
child relation
Offspring entities and appointments
Active 4
  • 1
    Unit 3 Bell Court, Felinfach Fforestfach, Swansea
    Active Corporate (3 parents)
    Equity (Company account)
    99 GBP2023-12-31
    Person with significant control
    2016-09-15 ~ now
    CIF 4 - Ownership of shares – 75% or more → OE
    CIF 4 - Ownership of voting rights - 75% or more → OE
    CIF 4 - Right to appoint or remove directors as a member of a firm → OE
    CIF 4 - Has significant influence or control as a member of a firm → OE
  • 2
    Unit 3 Bell Court, Felinfach, Fforestfach, Swansea
    Active Corporate (3 parents)
    Equity (Company account)
    99 GBP2023-12-31
    Person with significant control
    2016-09-15 ~ now
    CIF 3 - Ownership of shares – 75% or more → OE
    CIF 3 - Ownership of voting rights - 75% or more → OE
    CIF 3 - Right to appoint or remove directors as a member of a firm → OE
    CIF 3 - Has significant influence or control as a member of a firm → OE
  • 3
    Unit 3 Bell Court, Swansea West Business Park Fforestfach, Swansea
    Active Corporate (3 parents)
    Equity (Company account)
    99 GBP2023-12-31
    Person with significant control
    2016-09-15 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
    CIF 2 - Right to appoint or remove directors as a member of a firm → OE
    CIF 2 - Has significant influence or control as a member of a firm → OE
  • 4
    3 Felinfach, Fforestfach, Swansea
    Active Corporate (3 parents)
    Equity (Company account)
    99 GBP2023-12-31
    Person with significant control
    2016-09-15 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors as a member of a firm → OE
    CIF 1 - Has significant influence or control as a member of a firm → OE

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.